Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for … Read more
Market Cap & Net Worth: Psyence Biomedical Ltd. Warrant (PBMWW)
Psyence Biomedical Ltd. Warrant (NASDAQ:PBMWW) has a market capitalization of $165.24 ($165.24) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #45899 globally and #14374 in its home market, demonstrating a -6.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Psyence Biomedical Ltd. Warrant's stock price $0.02 by its total outstanding shares 9180 (9.18K).
Psyence Biomedical Ltd. Warrant Market Cap History: 2024 to 2026
Psyence Biomedical Ltd. Warrant's market capitalization history from 2024 to 2026. Data shows change from $127.60 to $165.24 (-21.17% CAGR).
Psyence Biomedical Ltd. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Psyence Biomedical Ltd. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PBMWW by Market Capitalization
Companies near Psyence Biomedical Ltd. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Psyence Biomedical Ltd. Warrant by market ranking:
- TFBS Bioscience Inc. (TWO:6939): Ranked #45890 globally with a market cap of $5.43K USD ( NT$179.69K TWD).
- SMARTONE TELE (SMA.SG) (STU:SMA): Ranked #45891 globally with a market cap of $5.43K USD ( €5.29K EUR).
- SMARTONE TELE (MU:SMA): Ranked #45900 globally with a market cap of $5.38K USD ( €5.24K EUR).
- L B Finance PLC (CM:LFINN0000): Ranked #45901 globally with a market cap of $5.37K USD ( SLRs1.57 Million LKR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #45890 | TFBS Bioscience Inc. | TWO:6939 | $5.43K | NT$19.10 |
| #45891 | SMARTONE TELE (SMA.SG) | STU:SMA | $5.43K | €0.54 |
| #45900 | SMARTONE TELE | MU:SMA | $5.38K | €0.56 |
| #45901 | L B Finance PLC | CM:LFINN0000 | $5.37K | SLRs165.00 |
Psyence Biomedical Ltd. Warrant Historical Marketcap From 2024 to 2026
Between 2024 and today, Psyence Biomedical Ltd. Warrant's market cap moved from $127.60 to $ 165.24, with a yearly change of -21.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $165.24 | -2.70% |
| 2025 | $169.83 | +33.09% |
| 2024 | $127.60 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Psyence Biomedical Ltd. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $165.24 USD |
| MoneyControl | $165.24 USD |
| MarketWatch | $165.24 USD |
| marketcap.company | $165.24 USD |
| Reuters | $165.24 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.